Pfizer/BioNTech | Business Post

Analysis: Can we end the pandemic?

The possibility for more infectious and deadly variants appears endless – it will take a number of measures and innovations to subdue Covid-19 in future

Irish people under 30 should not be given AstraZeneca vaccine, epidemiologist says

When the incidence of Covid-19 is low, the potential harms to 20-29 year olds from the vaccine outweighed the benefits of preventing ICU admissions through vaccination, the MHRA found

Vaccination of community pharmacists to start this week

Move could result in vaccines being administered to the public at local pharmacies by the end of March

Early data shows that Britain’s vaccine programme is working

The over-80s benefited most with the weekly average for new cases falling more

Lucinda Creighton: This is a war, and Big Pharma must be conscripted into battle

The EU’s response to the vaccine roll-out has been dispiriting. Massive state intervention is urgently needed to ramp up vaccine production by pharma giants

Sunday Interview: Paul Reid of Pfizer Healthcare Ireland

The country manager on the development of the pioneering vaccine and why Ireland will not be used as a manufacturing base for it in the short term

Fewer GP surgeries will be able to offer vaccination to over-70s

Tánaiste says rollout to older people will be slower following recommendation that Pfizer and Moderna vaccines, rather than AstraZeneca, should be used for this group

EMA approves extraction of six doses of Pfizer vaccine from five-dose vials

Certain hospitals in Ireland have managed to extract seven doses from Pfizer-BioNtech vials

Vaccination nation: the race is on

As the government ramps up the rollout effort to seven days a week, how do we compare to other countries?